- Home
- BKE vs AZTA Comparison
BKE vs AZTA Comparison
Compare BKE & AZTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BKE
- AZTA
- Stock Information
- Founded
- BKE 1948
- AZTA 1978
- Country
- BKE United States
- AZTA United States
- Employees
- BKE N/A
- AZTA N/A
- Industry
- BKE Clothing/Shoe/Accessory Stores
- AZTA Industrial Machinery/Components
- Sector
- BKE Consumer Discretionary
- AZTA Technology
- Exchange
- BKE Nasdaq
- AZTA Nasdaq
- Market Cap
- BKE 2.0B
- AZTA 1.8B
- IPO Year
- BKE 1992
- AZTA 1995
- Fundamental
- Price
- BKE $37.75
- AZTA $34.11
- Analyst Decision
- BKE Hold
- AZTA Buy
- Analyst Count
- BKE 1
- AZTA 4
- Target Price
- BKE $41.00
- AZTA $58.75
- AVG Volume (30 Days)
- BKE 755.3K
- AZTA 713.3K
- Earning Date
- BKE 03-14-2025
- AZTA 05-07-2025
- Dividend Yield
- BKE 9.96%
- AZTA N/A
- EPS Growth
- BKE N/A
- AZTA N/A
- EPS
- BKE 3.89
- AZTA N/A
- Revenue
- BKE $1,217,689,000.00
- AZTA $662,108,000.00
- Revenue This Year
- BKE $2.41
- AZTA N/A
- Revenue Next Year
- BKE $4.17
- AZTA $5.58
- P/E Ratio
- BKE $10.06
- AZTA N/A
- Revenue Growth
- BKE N/A
- AZTA 5.36
- 52 Week Low
- BKE $34.67
- AZTA $35.06
- 52 Week High
- BKE $54.25
- AZTA $63.58
- Technical
- Relative Strength Index (RSI)
- BKE 41.99
- AZTA 30.18
- Support Level
- BKE $39.07
- AZTA $35.06
- Resistance Level
- BKE $39.98
- AZTA $38.57
- Average True Range (ATR)
- BKE 1.25
- AZTA 1.73
- MACD
- BKE 0.49
- AZTA 0.06
- Stochastic Oscillator
- BKE 62.78
- AZTA 4.11
About BKE Buckle Inc. (The)
Buckle Inc is a retailer of casual apparel, footwear, and accessories. The company retails medium to better-priced casual apparel, footwear, and accessories for fashion-conscious young men and women. It retails under the brand names 'Buckle' and 'The Buckle'. Buckle markets a wide selection of mostly brand-name casual apparel including denim, other casual bottoms, tops, sportswear, outerwear, accessories, and footwear.
About AZTA Azenta Inc.
Azenta Inc is a provider of life sciences solutions, enabling impactful breakthroughs and therapies to market faster. It provides a full suite of reliable cold-chain sample management solutions and genomic services across areas such as drug development, clinical research and advanced cell therapies for the industry's top pharmaceutical, biotech, academic and healthcare institutions globally. The company has two reportable segments that are Life Sciences Products and Life Sciences Services. It generates a substantial part of its revenue from its Life Sciences Services segment.